SHANF yields 153.14% · JNJ yields 2.13%● Live data
📍 SHANF pulled ahead of the other in Year 1
Combined, SHANF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHANF + JNJ for your $10,000?
Shandong Molong Petroleum Machinery Company Limited engages in the design, research and development, production, and sale of products for the energy equipment industry in the People's Republic of China. The company operates through Pipe Products, Three Kinds of Pumping Units, Petroleum Machinery Parts, Tube Blank, High-End Castings and Forgings, and Others segments. The company's products include API and non API casing products, line pipe products, precision steel pipes, hydraulic prop tubes, fluid pipes, cylinder tubes, and boiler tubes; sucker rods; and valve body, cylinder liners, gate valves, and billet products. Its products are used in petroleum, natural gas, coalbed methane, shale gas, machinery processing, urban pipe network, etc., as well as used in equipment for oil and gas drilling, and wind turbine castings. In addition, the company engages in the research of new materials for energy equipment; production and sale of metal casting and forging; sea water desalination activities; waste heat and gas power generation activities; and manufacture and sale of special equipment. It also exports its energy equipment. Shandong Molong Petroleum Machinery Company Limited was founded in 2001 and is based in Shouguang City, China.
Full SHANF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.